Neurocrine Biosciences, Inc. · NASDAQ:NBIX
Morrow George J exercised options for 3,318 Neurocrine Biosciences, Inc. shares (Form 4)
Traded May 21, 2026 · Filed May 21, 2026
On May 21, 2026, Morrow George J (Director) exercised options for 3,318 Neurocrine Biosciences, Inc. shares, leaving 10,386 shares. Filed May 21, 2026 (Form 4).
- Options exercised
- 3,318 shares
- Holding after
- 10,386 shares
- Trading plan
- No
- Role
- Director
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| May 21, 2026 | Common Stock | Option exercise | 3,318 | 10,386 | Direct |